| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1749-6632.2012.06707.X |
| P698 | PubMed publication ID | 23050812 |
| P50 | author | Annalucia Serafino | Q56855052 |
| Francesca Pica | Q57243854 | ||
| Paola Sinibaldi Vallebona | Q58893805 | ||
| P2093 | author name string | Enrico Garaci | |
| Federica Andreola | |||
| Pasquale Pierimarchi | |||
| Roberta Gaziano | |||
| Manuela Zonfrillo | |||
| Noemi Moroni | |||
| P2860 | cites work | Human monocyte-derived dendritic cells differentiated in the presence of IL-2 produce proinflammatory cytokines and prime Th1 immune response | Q57235935 |
| Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C. | Q27473018 | ||
| Thymosin-alpha1 stimulates maturation of CD34+ stem cells into CD3+4+ cells in an in vitro thymic epithelia organ coculture model | Q30737100 | ||
| Thymosin activity in patients with cellular immunodeficiency | Q33899845 | ||
| Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application | Q34117986 | ||
| Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma | Q34523575 | ||
| Phagocytosis of microbes: complexity in action | Q34542300 | ||
| Thymosin alpha 1: from bench to bedside | Q34643499 | ||
| Thymosins: chemistry and biological properties in health and disease | Q35753541 | ||
| Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance | Q36818200 | ||
| Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones | Q37395527 | ||
| Thymosin alpha1 to harness immunity to pathogens after haploidentical hematopoietic transplantation | Q37763979 | ||
| Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B. | Q40934401 | ||
| Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling | Q44776004 | ||
| Activation of tumor-associated macrophages by thymosin alpha 1. | Q44786508 | ||
| Combination treatment with zidovudine, thymosin alpha 1 and interferon-alpha in human immunodeficiency virus infection | Q45783241 | ||
| Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice. | Q54275933 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 13-20 | |
| P577 | publication date | 2012-10-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Thymosin α1 as a stimulatory agent of innate cell-mediated immune response | |
| P478 | volume | 1270 |
| Q26774775 | A Review of GM-CSF Therapy in Sepsis |
| Q33749999 | Immunotherapy - a potential new way forward in the treatment of sepsis |
| Q28553440 | Proteomic Signatures of Thymomas |
| Q94571886 | Reduction of FoxP3+ Tregs by an immunosuppressive protocol of rapamycin plus Thymalfasin and Huaier extract predicts positive survival benefits in a rat model of hepatocellular carcinoma |
| Q34177314 | Role of circulating lymphocytes in patients with sepsis |
| Q39650675 | Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases. |
| Q92418254 | Severe Gastric Mycormycosis Infection Followed by Cytomegalovirus Pneumonia in a Renal Transplant Recipient: A Case Report and Concise Review of the Literature |
| Q38830449 | Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resection |
| Q38768132 | Thymosin alpha 1 and HIV-1: recent advances and future perspectives |
| Q40812029 | Thymosin α1 modifies podosome architecture and promptly stimulates the expression of podosomal markers in mature macrophages |
| Q57485164 | Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application |
Search more.